Company / Cost of Revenue
Indivior Cost of Revenue History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cost of Revenue
$246.0M
FY2025
5-year range
$151.0M / $246.0M
FY2022-FY2025
Trend
+6.5%
vs FY2024
Sector context
#32 of 85
Health Care
What the data says
At $246M, Indivior's cost of revenue ranks #54 of 85 in the Health Care sector. Cost of Revenue has increased for 3 consecutive years, from $151M in FY2022 to $246M in FY2025.
Based on SEC 10-K filings.
$246M in FY2025 with a 3-year CAGR of +17.7%.
Increased from $174M to $246M over the past 2 years.
Health Care sector context is included.
Cost of Revenue over time
Growth rates
- 3-Year CAGR
- +17.7%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#54 of 85 in Health CareTop 62% of 85This company $246.0M Sector average $2.0B
▼
-87.6% below sector average
Key checks
Key Insights
- Indivior's cost of revenue has grown for 3 consecutive years.
- 3-year CAGR of +17.7%, indicating consistent growth.
- In FY2025, cost of revenue increased 6.5% year-over-year.
- Ranks #32 out of 85 companies in the Health Care sector.
Company context
Key Data Points
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cost of RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $246.0M | +6.5% |
| FY2024 | $231.0M | +32.8% |
| FY2023 | $174.0M | +15.2% |
| FY2022 | $151.0M | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026